Skip to main content

Genix Pharmaceuticals: Top 25 Performing Stocks Year-to-Date on TSX Venture Exchange (GENX)

AI-generated - The Globe and Mail - Wed Jan 17, 2024

Genix Pharmaceuticals Corp is among the group of top performing stocks year-to-date on the TSX Venture Exchange. This means each stock on this list has seen its share price grow at a faster rate than the rest of the market so far this year.

This report is generated monthly. It highlights the 25 companies with the greatest percentage increase in share price year-to-date. Stocks in this category are generally held for appreciation or speculation.

Companies experiencing dramatic increases in share price can do so for a variety of reasons – including bullish changes in sector outlook, potential corporate takeover, or the company has restructured and earnings are better than expected.

SymbolNameTotal ReturnPeriod
CNSContagious Gaming Inc300YTD
GKOGeekco Technologies Corp300YTD
GHLGoldhills Holding Ltd200YTD
FWTCForward Water Technologies Corp150YTD
PVISParvis Invest Inc137.5YTD
LBCLibero Copper & Gold Corp133.333333YTD
SPZSuperBuzz Inc125YTD
AAUAngold Resources Ltd104.761905YTD
AMMOBullet Exploration Inc100YTD
CRTSCortus Metals Inc100YTD
GENXGenix Pharmaceuticals Corp100YTD
ISGIInsuraGuest Technologies Inc100YTD
JPIMJasper Commerce Inc100YTD
LOTTomaGold Corp100YTD
MAPMaple Peak Investments Inc100YTD
OEEMemex Inc100YTD
ORMOrford Mining Corp100YTD
TBIXTrustBIX Inc100YTD
NLNorthern Lion Gold Corp96.153846YTD

All data provided as of January 17, 2024.

More about Genix Pharmaceuticals Corp

Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.

Genix Pharmaceuticals Corp is listed under GENX on the TSX Venture Exchange.

Artificial intelligence at Report on Business

Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.